Have a guess!, page-33

First 33 Last

Share
Profile

Follow
walkingeagle

840 Posts.

4

06/03/18

11:41

Post #: 31554187
Share

Originally posted by walkingeagle ↑

Only the most dogged, naive or cerebrally challenged holders will have retained their shares in SGH. Most of these will probably hold them until the bitter (or indeed sweet) end, whenever and however that comes. Others may seek a target price that is advertised, but this will quickly disappear into the ether if any serious selling is attempted - the market makers won't take the shares if they don't have buyers on their books. Buyers are probably people who don't understand that the value of what they're buying is fundamentally dependent on the actions of a limited number of hedge funds and investment banks acting in concert who have total control over the company and anything that happens to it (and the 5% minority). They undoubtedly have their own interests very firmly in mind.

There's simply more demand than supply on the tiny volumes presently being traded. It is as close to a false market as it is possible to get imv.

It is just a view - maybe SGH will turn out to be worth gazillions but that doesn't mean the 5% minority will see any of it. It's totally outside their control. Actually, at $4.30 per share, 'the market' is suggesting SGH is presently worth $300m. Do its profits/future prospects and other circumstances really support this?

Wake up and smell the coffee.

imo/dyor

Expand

PS - having written all the above, I'm not sure what scholars would say SGH shares are worth. Can you ask them please, SWC? Remind us again why the DCF method is the only way to value your tiny minority holding.

Probably mistakenly in your considered view, I don't think it is. But I only spent 4 decades finding this out.

I'm surprised you've made your way back onto this forum after misleading so many people for so long. 'Clueless' doesn't even begin to describe you.

SGH Price at posting: $4.90 Sentiment: Sell Disclosure: Not Held
3 Upvote

1 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

There are more pages in this discussion • 6 more messages in this thread...

First 33 Last

Add SGH (ASX) to my watchlist

Have a guess!, page-33

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News